Johnson & Johnson (BOG:JNJCO) Total Liabilities: COP439,955,588 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOG:JNJCO Johnson & Johnson BOG:JNJCO
81 GF Score
Price COP824,700.00
GF Value COP623,837.44
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Total Liabilities?

Johnson & Johnson BOG:JNJCO 81 Total Liabilities is COP439,955,588 Mil as of Mar. 2026. GuruFocus rates BOG:JNJCO with a GF Score™ of 81/100 and a GF Value™ of COP623,837.44. The stock has 7 warning signs investors should review.

Johnson & Johnson's Total Liabilities for the quarter that ended in Mar. 2026 was COP439,955,588 Mil.

Johnson & Johnson's quarterly Total Liabilities declined from Sep. 2025 (COP444,959,401.11 Mil) to Dec. 2025 (COP440,124,961.29 Mil) and declined from Dec. 2025 (COP440,124,961.29 Mil) to Mar. 2026 (COP439,955,588.40 Mil).

Johnson & Johnson's annual Total Liabilities increased from Dec. 2023 (COP395,662,547.72 Mil) to Dec. 2024 (COP481,581,440.84 Mil) but then declined from Dec. 2024 (COP481,581,440.84 Mil) to Dec. 2025 (COP440,124,961.29 Mil).

Johnson & Johnson Total Liabilities Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Total Liabilities Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 425,629,941.77 527,365,044.36 395,662,547.72 481,581,440.84 440,124,961.29

Johnson & Johnson Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 463,736,534.24 444,959,401.11 440,124,961.29 439,955,588.40 0.00
BOG:JNJCO
81GF Score
Johnson & Johnson BOG:JNJCO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Johnson & Johnson's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=202456135.626+(147516259.779+36910858.855
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+25401463.567+26022379.92+1817863.539)
=440,124,961

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=745137028.01-305012066.724
=440,124,961

Johnson & Johnson's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=212120131.823+(137920718.465+37516846.38
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+25767105.209+24844620.056+1817863.539)
=439,955,588

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=738333594.888-298378006.484
=439,955,588

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of COP439,955,588 Mil mean?
Johnson & Johnson (BOG:JNJCO) has a Total Liabilities of COP439,955,588 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Johnson & Johnson and its competitors.
Is Johnson & Johnson's Total Liabilities too high?
Johnson & Johnson's current Total Liabilities is COP439,955,588 Mil. Overall, Johnson & Johnson has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Total Liabilities compare to ABBV and MRK?
Johnson & Johnson's Total Liabilities of COP439,955,588 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Johnson & Johnson and its competitors. Johnson & Johnson's current Total Liabilities is COP439,955,588 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Johnson & Johnson (BOG:JNJCO) has a current Total Liabilities of COP439,955,588 Mil. The stock's GF Value™ is COP623,837.44, compared to a current price of COP824,700.00 — trading 32.2% above its estimated fair value. The current Total Liabilities is COP439,955,588 Mil. Johnson & Johnson's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Johnson & Johnson (BOG:JNJCO), the current Total Liabilities is COP439,955,588 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (BOG:JNJCO) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of COP824,700.00 is trading 32.2% above its estimated GF Value™ of COP623,837.44.

Key valuation signals for BOG:JNJCO:

  • Total Liabilities: COP439,955,588 Mil
  • GF Value™: COP623,837.44 vs. price of COP824,700.00 (32.2% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the BOG:JNJCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
81GF Score

Get the complete analysis for BOG:JNJCO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

COP824,700.00
Price
COP623,837.44
GF Value